Reports and Data has released a report predicting that the global Genome Editing Market will reach USD 15.7 billion in 2032, with a CAGR of 15.2% during the forecast period. The growth of the market is driven by factors such as the increasing application of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome in various biotechnology fields and the rising investments made by governments and private investors in biotechnology and biomedical research.
Get a free sample PDF of the report, visit @
Genome editing, also referred to as gene editing or genome engineering, enables scientists to modify or alter gene sequences in living organisms. The market for genome editing is extensively utilized by academic & government research institutions, biotechnology firms, and pharmaceutical companies. In 2020, the pharmaceutical segment held the largest share of revenue in the global market, owing to the growing use of gene editing technology in pharmaceutical R&D activities.
Over the forecast period, the North American region is anticipated to dominate the market in terms of revenue, with the United States and Canada contributing significantly to revenue growth. This can be attributed to factors such as rapid advancements in genome editing technologies, a surge in demand for genetically modified crops, and a growing emphasis on R&D activities associated with gene therapy. Europe secured the second-largest revenue share in the global market in 2020, primarily due to increased investments in genome editing technologies driving revenue growth in this region.
The Asia Pacific region accounted for a 23.4% revenue share in the global market in 2020 and is expected to register the fastest revenue CAGR compared to other regional markets over the forecast period. This can be attributed to the rising prevalence of various infectious diseases.
To know more about the latest insights of the report, visit @
The market report includes some key highlights such as the launch of Horizon Discovery Group’s predesigned synthetic Single Guide RNA (sgRNA) in December 2019. This would enable researchers to obtain reliable gene knockouts in difficult-to-edit, complex cell types, and experimental models. The CRISPR segment accounted for the largest revenue share in the global market in 2020 due to its advantages such as ease of use, enhanced efficacy, and cost-effectiveness.
The market report also includes some players in the market, including Thermo Fisher Scientific, Merck & Co, Horizon Discovery Limited, Lonza, GenScript, Eurofins Scientific, Precision Biosciences, Oxford Genetics, Intellia Therapeutics, and Sangamo Therapeutics.
The genome editing market has been segmented by Reports and Data based on technology, product & service, application, end-use, and region. The technology segment includes Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Zinc-finger Nucleases (ZFNs), Transcription Activator-like Effector Nucleases (TALEN), Antisense, and Others. The product and service segment includes Software & Systems, Reagents & Consumables, and Services. The application segment includes Cell Line Engineering, Diagnostic Applications, Genetic Engineering, Drug Discovery & Development, and Others. Finally, the end-use segment includes Pharmaceutical Companies, Biotechnology Companies, and Academic & Government Research Institutes. The regional outlook includes North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Request a customized copy of the report @
Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.
Browse for more reports…
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.